Firebrick Pharma Boosts Funds for Marketing Drive

Firebrick Pharma Limited (AU:FRE) has released an update.

Firebrick Pharma Limited has successfully completed its Share Purchase Plan, raising $635,600 with the participation of around 100 shareholders, and anticipates an additional $158,700 from a Shortfall Placement. The capital raised, alongside recent RDTI funds, will be used to expand marketing for the company’s Nasodine® Nasal Spray in Singapore and the US, targeting healthcare professionals, pharmacy distributions, and marketing partnerships.

For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.